Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Drug Metab Dispos ; 14(2): 271-6, 1986.
Article in English | MEDLINE | ID: mdl-2870906

ABSTRACT

Antipyrine metabolite kinetics have been characterized in rats receiving an intravenous infusion of either saline, cimetidine, or metyrapone. 14CO2 exhalation rate-time profiles following [N-methyl-14C] antipyrine administration demonstrate that, when either cimetidine or metyrapone is maintained at a steady state plasma concentration, a constant degree of inhibition is evident. Under the conditions imposed in this in vivo study, the inhibitory potency of metyrapone is approximately 6 times that observed with cimetidine. Rate constants for the formation of 4-hydroxy-, 3-hydroxymethyl-, and norantipyrine have been calculated using breath and urinary metabolite data under the steady state inhibitory states. Metyrapone nonselectively inhibits the formation of all three oxidative metabolites by approximately one-third. Cimetidine inhibition is selective where rates of 3-methyl-hydroxylation and N-demethylation are reduced by 50% yet 4-hydroxylation is unaffected. The value of assessing inhibitory responses under steady state conditions is discussed and the nonlinear nature of the kinetics of inhibition, when a single bolus dose of inhibitor is used, is illustrated by means of computer simulation.


Subject(s)
Antipyrine/metabolism , Cimetidine/pharmacology , Metyrapone/pharmacology , Animals , Antipyrine/analogs & derivatives , Antipyrine/antagonists & inhibitors , Antipyrine/urine , Carbon Dioxide/biosynthesis , Edaravone , Kinetics , Male , Rats , Rats, Inbred Strains
SELECTION OF CITATIONS
SEARCH DETAIL